BAT1 inhibitors belong to a distinct chemical class that plays a crucial role in modulating cellular processes through their interaction with a specific enzyme. The term "BAT1" refers to the enzyme Bromodomain Adjacent to Zinc finger domain 1, which is a member of the bromodomain and extraterminal domain (BET) protein family. These inhibitors are designed to selectively target BAT1, altering its activity and influencing downstream cellular events. BAT1, characterized by its bromodomain, serves as an epigenetic reader, recognizing acetylated lysine residues on histone proteins. This recognition is integral to the regulation of gene expression, as it facilitates the recruitment of transcriptional machinery to chromatin. BAT1 inhibitors, therefore, function by disrupting the interaction between the bromodomain of BAT1 and acetylated lysines, thereby modulating gene transcription and influencing cellular processes governed by these transcriptional changes.
The development of BAT1 inhibitors has garnered considerable attention in the field of chemical biology, as they offer a valuable tool to study and manipulate epigenetic processes. The specificity of these inhibitors for BAT1, within the BET family, allows for a nuanced exploration of the distinct functions of individual bromodomain-containing proteins. Researchers are keenly interested in unraveling the intricate molecular mechanisms through which BAT1 inhibitors exert their effects, aiming to gain insights into the broader regulatory networks that govern gene expression and cellular function.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $105.00 $408.00 $1224.00 | 35 | |
Known to inhibit CRM1, a protein that cooperates with BAT1 in RNA export. This inhibition can indirectly affect BAT1 function. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
It inhibits SF3b complex, a component of the spliceosome, indirectly affecting BAT1's role in splicing. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
It targets the SF3b complex, thus impacting the splicing process where BAT1 plays a role. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A pre-mRNA splicing inhibitor that can indirectly impact BAT1's function in splicing. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
Another HSP90 inhibitor, could indirectly influence BAT1's function. | ||||||
17-DMAG | 467214-20-6 | sc-202005 | 1 mg | $201.00 | 8 | |
HSP90 inhibitor that can indirectly affect the functioning of BAT1. | ||||||
Ganetespib | 888216-25-9 | sc-364496 sc-364496A | 10 mg 250 mg | $268.00 $1020.00 | ||
It inhibits HSP90, indirectly influencing BAT1's role. | ||||||
AT13387 | 912999-49-6 | sc-364415 sc-364415A | 10 mg 50 mg | $555.00 $1606.00 | ||
Another HSP90 inhibitor, could indirectly affect BAT1's function. |